Evidence map›Paper›PMID 34093588›Full record

ArticleFrontiers in immunology2021

Lactoferrin Retargets Human Adenoviruses to TLR4 to Induce an Abortive NLRP3-Associated Pyroptotic Response in Human Phagocytes.

Coraline Chéneau, Karsten Eichholz, Tuan Hiep Tran, Thi Thu Phuong Tran, Océane Paris, Corinne Henriquet, Jeffrey J Bajramovic, Martine Pugniere, Eric J Kremer

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Viral vector vaccines.Current opinion in immunology · 2022
    Review
  14. Adenovirus-based vaccines-a platform for pandemic preparedness against emerging viral pathogens.Molecular therapy : the journal of the American Society of Gene Therapy · 2022
    Review
  15. Article
  16. Adenovirus vector-based vaccine for infectious diseases.Drug metabolism and pharmacokinetics · 2022
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Coraline ChéneauInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Karsten EichholzInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Tuan Hiep TranInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Thi Thu Phuong TranInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Océane ParisInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Corinne HenriquetInstitut de Recherche en Cancérologie de Montpellier, INSERM, Université Montpellier, Institut Régional du Cancer, Montpellier, France.
Jeffrey J BajramovicAlternatives Unit, Biomedical Primate Research Centre, Rijswijk, Netherlands.
Martine PugniereInstitut de Recherche en Cancérologie de Montpellier, INSERM, Université Montpellier, Institut Régional du Cancer, Montpellier, France.
Eric J KremerInstitut de Génétique Moléculaire de Montpellier, Université de Montpellier, CNRS, Montpellier, France.
Centre National de la Recherche Scientifique · FRInstitut de Génétique Moléculaire de Montpellier · FRUniversité de Montpellier · FRBiomedical Primate Research Centre · NLInserm · FRInstitut de Recherche en Cancérologie de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite decades of clinical and preclinical investigations, we still poorly grasp our innate immune response to human adenoviruses (HAdVs) and their vectors. In this study, we explored the impact of lactoferrin on three HAdV types that are being used as vectors for vaccines. Lactoferrin is a secreted globular glycoprotein that influences direct and indirect innate immune response against a range of pathogens following a breach in tissue homeostasis. The mechanism by which lactoferrin complexes increases HAdV uptake and induce maturation of human phagocytes is unknown. We show that lactoferrin redirects HAdV types from species B, C, and D to Toll-like receptor 4 (TLR4) cell surface complexes. TLR4-mediated internalization of the HAdV-lactoferrin complex induced an NLRP3-associated response that consisted of cytokine release and transient disruption of plasma membrane integrity, without causing cell death. These data impact our understanding of HAdV immunogenicity and may provide ways to increase the efficacy of HAdV-based vectors/vaccines.

Indexed as

Adenoviridae InfectionsAdenoviruses, HumanCytokinesFlow CytometryHumansImmunity, InnateLactoferrinNLR Family, Pyrin Domain-Containing 3 ProteinPhagocytesToll-Like Receptor 4CytokinesLactoferrinNLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanTLR4 protein, humanToll-Like Receptor 4adenovirusdendritic cell (DC)IL-1βLactoferrinTLR4 (Toll-like receptor 4)

Identifiers

PMID34093588
PMCPMC8173049
OpenAlexW3163020688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.